Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Determining cause of skin lesions in COVID-19 patients remains challenging

Publish date:: August 13, 2020

Key clinical point: The COVID-19 pandemic is driving dermatologists to describe new skin findings associated with the infection and its treatment.

Major finding: The frequency of drug reactions in patients with COVID-19 remains unknown.

Study details: The authors reviewed treatments used in COVID-19 patients with the potential for skin reactions.

Disclosures: The study received no outside funding. The researchers had no financial conflicts to disclose.

Citation:

Martinez-Lopez A et al. J Am Acad Dermatol. 2020. doi: 10.1016/j.jaad.2020.08.006.

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in COVID-19 Updates

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Obesity, hypoxia predict severity in children with COVID-19,

Whales, seals, and dolphins: Will SARS-CoV-2–contaminated wastewater prove a killer?,

COVID-19 in pregnancy raises risk of preterm birth and severe disease,

New case suggestive of in utero SARS-CoV-2 transmission,